AP
The Food and Drug Administration said that expanding availability of the injectable drug would provide a much-needed option for children who suffer from Crohn's, in which chronic inflammation of the walls of the intestines can cause diarrhea, cramping, abdominal pain and bleeding. In 1998, Remicade became the first approved treatment for Crohn's disease in adults.
More... |